Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 1.756
-0.066 (-3.62%)
At close: Aug 12, 2026
Medivir AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -90.5 | -94.4 | -123.32 | -89.32 | -88.77 | -63.13 |
Depreciation & Amortization | 2.69 | 2.69 | 2.73 | 2.74 | 2.57 | 2.59 |
Other Amortization | - | - | - | - | - | 0.01 |
Asset Writedown & Restructuring Costs | 32.21 | 32.21 | - | - | - | - |
Stock-Based Compensation | - | - | - | 0.47 | - | - |
Other Operating Activities | 0.82 | 1.12 | 1.24 | - | - | -0.64 |
Change in Accounts Receivable | -0.16 | -0.16 | 5.61 | -4.11 | -0.86 | 4.84 |
Change in Other Net Operating Assets | -4.6 | -14.8 | -10.45 | 30.56 | -14.77 | 7.59 |
Operating Cash Flow | -59.55 | -73.35 | -124.19 | -59.67 | -101.82 | -48.73 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | - | - | -0.38 | - |
Other Investing Activities | - | - | - | -0.26 | - | - |
Investing Cash Flow | - | - | - | -0.26 | -0.38 | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -2.68 | -2.47 | -1.98 | -1.94 | -2.48 |
Net Debt Issued (Repaid) | -2.68 | -2.68 | -2.47 | -1.98 | -1.94 | -2.48 |
Issuance of Common Stock | 196.43 | 151.43 | 20.37 | 129.74 | - | 222.76 |
Other Financing Activities | -20.12 | -18.72 | -0.7 | -15.69 | 0.41 | -20.89 |
Financing Cash Flow | 173.63 | 130.03 | 17.2 | 112.07 | -1.54 | 199.4 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | - | -0.06 | 0 | 0.49 |
Miscellaneous Cash Flow Adjustments | -0.1 | - | - | - | 0 | - |
Net Cash Flow | 113.98 | 56.68 | -106.99 | 52.08 | -103.73 | 151.16 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -59.55 | -73.35 | -124.19 | -59.67 | -102.2 | -48.73 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -661.20% | -862.31% | -3564.61% | -781.67% | -2318.56% | -150.44% |
Free Cash Flow Per Share | -0.25 | -0.51 | -1.09 | -0.99 | -1.83 | -0.92 |
Levered Free Cash Flow | -59.56 | -72.16 | -82.65 | -28.88 | -69.4 | -26.48 |
Unlevered Free Cash Flow | -58.02 | -70.65 | -82.16 | -28.31 | -68.82 | -25.89 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | - | - | - | - | - | 1.21 |
Change in Working Capital | -4.76 | -14.96 | -4.84 | 26.44 | -15.63 | 12.44 |